Long-term cardiovascular outcomes in survivors of Kawasaki disease

Pediatrics

Volumn 133, Issue 2, 2014, Pages

  Holve, Taylor J ^a   Patel, Ajay ^a   Chau, Quyen ^a   Marks, Amy R ^b   Meadows, Alison ^a   Zaroff, Jonathan G ^a  

^a Kaiser San Francisco Medical Center   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Cardiovascular outcomes; Coronary aneurysm; Kawasaki disease; Vasculitis

Indexed keywords

CARDIOVASCULAR OUTCOMES; CORONARY ANEURYSM; KAWASAKI DISEASE; VASCULITIS;

ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEART DISEASES; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; SURVIVORS; TIME FACTORS; YOUNG ADULT;

EID: 84893317975     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1638     Document Type: Article

References (17)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 1967;16(3):178-222
2. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr. 1991;119 (2):279-282
3. Suda K, Iemura M, Nishiono H, et al. Longterm prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation. 2011;123(17):1836-1842
4. Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009;54(21):1911-1920
5. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol. 1996;28(1):253-257
6. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96(6): 1057-1061
7. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315(6):341-347
8. Iribarren C, Tolstykh I, Somkin CP, et al. Sex and racial/ethnic disparities in outcomes after acute myocardial infarction: a cohort study among members of a large integrated health care delivery system in northern California. Arch Intern Med. 2005; 165(18):2105-2113
9. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5): 703-710
10. Arellano MG, Petersen GR, Petitti DB, Smith RE. The California Automated Mortality Linkage System (CAMLIS). Am J Public Health. 1984;74(12):1324-1330
11. Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107(5):1095-1099
12. Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2007;92(1):43-47
13. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379-1385
14. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int. 2008;50(3): 287-290
15. Nakamura Y, Aso E, Yashiro M, et al. Mortality among persons with a history of Kawasaki disease in Japan: mortality among males with cardiac sequelae is significantly higher than that of the general population. Circ J. 2008;72(1):134-138
16. Senzaki H. Long-term outcome of Kawasaki disease. Circulation. 2008;118(25):2763-2772
17. Yamakawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol. 1998;31(5): 1074-1080